Ai’s Potential to Disrupt Drug Development: BI Replay

On Demand

Duration: 37 Minutes

Original Date: January 07, 2026

First name

Last name

Business email

Business phone

Company

Job role

Industry

City

Country or Region

State or Province Optional

Yes, I would like to be contacted by a representative to learn more about Bloomberg's solutions and services.

What are you interested in learning more about?

By submitting this information, I agree to the privacy policy and to learn more about products and services from Bloomberg.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Join BI analysts Andrew Galler and Sam Fazeli on January 8, 2026 at 10am ET/3pm London to discuss the implications of a survey of 50 biopharma C-suite executives whose topics will include: - Applications of AI in the drug development process - The five year outlook on AI integration for pharmaceutical companies - Time and cost savings associated with AI's integration

Ai’s Potential to Disrupt Drug Development: BI Replay

Access a broad range of analysis, research, insight and actionable ideas with Bloomberg webinars.